Limaca Medical
Caesarea, Israel· Est.
Automated EUS biopsy device delivering consistent, high‑quality tissue for precision oncology.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Automated EUS biopsy device delivering consistent, high‑quality tissue for precision oncology.
Oncology
Technology Platform
Motorized endoscopic ultrasound (EUS) biopsy needle that automates tissue acquisition to provide consistent, high‑quality core samples in a single pass.
Opportunities
U.S.
market adoption supported by CMS reimbursement, expansion into Europe and Asia, and potential integration with major endoscope manufacturers.
Risk Factors
Clinician adoption barriers, competition from other automated biopsy devices, and reliance on reimbursement policies.
Competitive Landscape
Competes with manual EUS needles (e.g., Olympus, Boston Scientific) and emerging automated biopsy platforms; differentiation lies in motorized single‑pass core acquisition and FDA Breakthrough designation.